Characteristics of a Large Cohort of Patients with Autoimmune Pulmonary Alveolar Proteinosis in Japan
Yoshikazu Inoue(Fukujuji Hospital), Koh Nakata(Niigata University Medical and Dental Hospital), Koichiro Tatsumi(Chiba University), Bruce C. Trapnell(Cincinnati Children's Hospital Medical Center), Toru Arai(NHO Kinki Chuo Chest Medical Center), Masaaki Hojo(Saitama International Medical Center), Chinatsu Kaneko(Niigata University Medical and Dental Hospital), Toshinori Takada(Niigata University Medical and Dental Hospital), Etsuro Yamaguchi(Aichi Medical University), Ryosuke Eda(National Sanyo Hospital), Yoshiko Tsuchihashi(Nagasaki University), Jeffrey P. Krischer(University of South Florida), Yasunori Kasahara(Chiba University), Kazunori Oishi(The University of Osaka), Nobuyuki Hizawa(University of Tsukuba), Toshihiro Nukiwa(Tohoku University), Naohiko Tanaka(University of Tokyo Hospital), Ryushi Tazawa(Tohoku University), Toshio Ichiwata(Dokkyo University), Mitsunori Sakatani(NHO Kinki Chuo Chest Medical Center)
American Journal of Respiratory and Critical Care Medicine
January 17, 2008
Cited by 487
Related Papers
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
|New England Journal of Medicine|2010|5.6k
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
|Cancer Cell|2012|1.4k